A detailed history of Burgundy Asset Management Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Burgundy Asset Management Ltd. holds 1,342,734 shares of JNJ stock, worth $210 Million. This represents 2.14% of its overall portfolio holdings.

Number of Shares
1,342,734
Previous 1,161,816 15.57%
Holding current value
$210 Million
Previous $184 Million 6.78%
% of portfolio
2.14%
Previous 1.96%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $26.1 Million - $28.5 Million
180,918 Added 15.57%
1,342,734 $196 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $3.71 Million - $3.89 Million
23,902 Added 2.1%
1,161,816 $184 Million
Q4 2023

Feb 13, 2024

BUY
$145.6 - $158.88 $11.5 Million - $12.6 Million
79,065 Added 7.47%
1,137,914 $178 Million
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $20.3 Million - $22.8 Million
-130,536 Reduced 10.98%
1,058,849 $165 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $8.82 Million - $9.5 Million
-57,165 Reduced 4.59%
1,189,385 $197 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $57.8 Million - $69 Million
382,744 Added 44.31%
1,246,550 $193 Million
Q4 2022

Feb 10, 2023

SELL
$160.2 - $179.79 $1.25 Million - $1.4 Million
-7,778 Reduced 0.89%
863,806 $153 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $3.15 Million - $3.5 Million
-19,495 Reduced 2.19%
871,584 $142 Million
Q2 2022

Aug 10, 2022

SELL
$168.19 - $186.01 $57.8 Million - $64 Million
-343,945 Reduced 27.85%
891,079 $158 Million
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $3.99 Million - $4.53 Million
-25,248 Reduced 2.0%
1,235,024 $219 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $20.5 Million - $22.8 Million
-131,504 Reduced 9.45%
1,260,272 $216 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $24.4 Million - $27.1 Million
-150,977 Reduced 9.79%
1,391,776 $225 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $9.33 Million - $10 Million
-58,486 Reduced 3.65%
1,542,753 $254 Million
Q1 2021

May 14, 2021

SELL
$153.07 - $170.48 $61.8 Million - $68.8 Million
-403,620 Reduced 20.13%
1,601,239 $263 Million
Q4 2020

Feb 12, 2021

SELL
$137.11 - $157.38 $133 Million - $153 Million
-969,506 Reduced 32.6%
2,004,859 $316 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $3.06 Million - $3.35 Million
-21,791 Reduced 0.73%
2,974,365 $443 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $15.8 Million - $19.1 Million
-122,791 Reduced 3.94%
2,996,156 $421 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $47.9 Million - $66.4 Million
431,278 Added 16.05%
3,118,947 $409 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $8.61 Million - $9.89 Million
67,535 Added 2.58%
2,687,669 $392 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $22.7 Million - $25.4 Million
178,864 Added 7.33%
2,620,134 $339 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $70.2 Million - $77.2 Million
-535,394 Reduced 17.99%
2,441,270 $340 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $8.17 Million - $9.08 Million
64,954 Added 2.23%
2,976,664 $416 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $31.9 Million - $38.3 Million
-259,329 Reduced 8.18%
2,911,710 $376 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $4.98 Million - $5.85 Million
-40,921 Reduced 1.27%
3,171,039 $438 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $4.59 Million - $5.07 Million
38,478 Added 1.21%
3,211,960 $390 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $2.72 Million - $3.23 Million
21,770 Added 0.69%
3,173,482 $407 Million
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $5.8 Million - $6.34 Million
-44,166 Reduced 1.38%
3,151,712 $0
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $1.46 Million - $1.52 Million
11,257 Added 0.35%
3,195,878 $415 Million
Q2 2017

Sep 15, 2017

BUY
N/A
3,184,621
3,184,621 $421 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Burgundy Asset Management Ltd. Portfolio

Follow Burgundy Asset Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burgundy Asset Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Burgundy Asset Management Ltd. with notifications on news.